Common Contracts
6 similar Employment Agreement contracts by Aktis Oncology, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • January 5th, 2026 • Aktis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made between Aktis Oncology, Inc., a Delaware corporation (the “Company”), and Shulamit Ron-Bigger, PhD (the “Executive,” and together with the Company, the “Parties”) on December 18, 2025 and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the letter agreement between the Parties, dated August 4, 2022 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 5th, 2026 • Aktis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made between Aktis Oncology, Inc., a Delaware corporation (the “Company”), and Paul L. Feldman, PhD (the “Executive,” and together with the Company, the “Parties”) on December 18, 2025 and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the letter agreement between the Parties, dated October 26, 2022 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 5th, 2026 • Aktis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made between Aktis Oncology, Inc., a Delaware corporation (the “Company”), and Akos Czibere MD, PhD (the “Executive,” and together with the Company, the “Parties”) on December 18, 2025 and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the letter agreement between the Parties, dated June 19, 2024 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 5th, 2026 • Aktis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made between Aktis Oncology, Inc., a Delaware corporation (the “Company”), and Matthew Roden, PhD (the “Executive,” and together with the Company, the “Parties”) on December 18, 2025 and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the letter agreement between the Parties, dated September 24, 2021 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 5th, 2026 • Aktis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made between Aktis Oncology, Inc., a Delaware corporation (the “Company”), and Tyler Benedum, PhD (the “Executive,” and together with the Company, the “Parties”) on December 18, 2025 and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the letter agreement between the Parties, dated May 28, 2024 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 5th, 2026 • Aktis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made between Aktis Oncology, Inc., a Delaware corporation (the “Company”), and Kyle D. Kuvalanka (the “Executive,” and together with the Company, the “Parties”) on December 18, 2025 and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation the letter agreement between the Parties, dated October 29, 2025 (the “Prior Agreement”).